The Chinese vaccine was previously provided to such Arab countries as Morocco and Egypt, as the authorities are preparing for mass vaccinations amid the growing numbers of infected worldwide.
The UAE’s Ministry of Health and Prevention (MOHAP) has announced the official registration of the Beijing Institute of Biological Product’s inactivated COVID-19 vaccine.
The decision was made after the Department of Health Abu Dhabi reviewed Sinopharm CNBG’s interim analysis of its phase III trials (which included 31,000 volunteers in the UAE alone), showing 86% efficacy against the coronavirus.
A visitor wearing a face mask takes a photo of a model of a coronavirus and boxes for COVID-19 vaccines at a display by Chinese pharmaceutical firm Sinopharm at the China International Fair for Trade in Services (CIFTIS) in Beijing, Saturday, Sept. 5, 2020. With the COVID-19 pandemic largely under control, China’s capital on Saturday kicked off one of the first large-scale public events since the start of the coronavirus outbreak, as tens of thousands of attendees were expected to visit displays from nearly 2,000 Chinese and foreign companies showcasing their products and services.
According to the analysis, the drug has a 99% seroconversion rate and 100% effectiveness in preventing moderate and severe cases of the disease.
The UAE has been conducting phase 3 clinical trials of the Sinopharm vaccine since July and in September the authorities approved its emergency use in the country. At the same time, trials of the drug continue in Egypt, Jordan, and Bahrain.
Sourse: sputniknews.com
0.00 (0%) 0 votes
